Get 25% discount on our yearly plans! Subscribe now

Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets
Total Liability
Assets-to-Libability Ratio
Total Current Assets
Total Current Liability
Current Ratio
Quick Ratio
Debt to Equity Ratio
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News
Sean Whelan Appointed to Board of DirectorsANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vac...

DPLO | globenewswire | about 4 years ago | Neutral
Sean Whelan Appointed to Board of DirectorsANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vacan...

DPLO ZOM | finance.yahoo | about 4 years ago | Neutral
NYSE: DPLO Investor Notice: Lawsuit against Diplomat Pharmacy Inc announced by Shareholders FoundationSAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of Diplomat Pharmacy Inc (NYSE: DPLO).  Investors, who purchased shares of Diplomat Pharmacy Inc (NYSE: DPLO), have certain options and should cont...

DPLO | globenewswire | about 6 years ago | Neutral
APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO) and Encourages DPLO Investors to Contact the FirmNEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired Diplomat Pharmacy, Inc. (NYSE: DP...

DPLO | globenewswire | about 6 years ago | Neutral
APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO) and Encourages DPLO Investors to Contact the FirmNEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired Diplomat Pharmacy, Inc. (NYSE: DP...

DPLO | globenewswire | about 6 years ago | Neutral
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, CVS, UMC and AAPLNEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. D...

CVS DPLO UMC | globenewswire | about 6 years ago | Neutral
DEADLINE THURSDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmLOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE: DPLO) for violations of §§10(b) and 20(a) of the Securities Exchan...

DPLO | globenewswire | about 6 years ago | Neutral
CLASS ACTION UPDATE for DPLO, WTW, EB and AAPL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersNEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court an...

DPLO EB WTW | globenewswire | about 6 years ago | Neutral
DPLO FINAL DEADLINE REMINDER: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important April 25th Deadline in Securities Class Action Filed by the Firm – DPLONEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the “Class Period”) of the April 25, 2019 lead plaintiff deadlin...

DPLO | globenewswire | about 6 years ago | Neutral
Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLCNEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may conta...

AVEO CAG DPLO | globenewswire | about 6 years ago | Neutral

Profile

Diplomat Pharmacy Inc (DPLO)

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company operates through Specialty and PBM (pharmacy benefit management) segment. It provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company primarily focuses on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. It also offers PBM services, including electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, drug review and analysis, consulting services, data access, and reporting, information analysis, and preferred drug management programs to managed care organizations, self-insured employer groups, unions, and third-party healthcare plan administrators and worker's compensation payers. The company was founded in 1975 and is headquartered in Flint, Michigan.As of February 7, 2020, Diplomat Pharmacy, Inc. operates as a subsidiary of OptumRx, Inc.

Exchange: NYSE

IPO Date: 10/10/2014

Sector: Other

Industry: Other

Employees: 2132

Address: 4100 South Saginaw Street 48507,Flint,USA

www.diplomatpharmacy.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-